Dr. Reddys Laboratories Ltd.

Dr. Reddys Laboratories is currently trading at Rs. 4533.25, up by 233.05 points or 5.42% from its previous closing of Rs. 4300.20 on the BSE.

The scrip opened at Rs. 4375.00 and has touched a high and low of Rs. 4543.00 and Rs. 4344.75 respectively. So far 101042 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4,543.00 on 30-July-2020 and a 52 week low of Rs. 2352.00 on 14-Aug-2019.

Last one week high and low of the scrip stood at Rs. 4543.00 and Rs. 3963.85 respectively. The current market cap of the company is Rs. 74443.91 crore.

The promoters holding in the company stood at 26.74%, while Institutions and Non-Institutions held 43.97% and 15.25% respectively.

Dr. Reddy's Laboratories has reported 73.36% rise in its net profit of Rs 950.20 crore for the quarter ended June 30, 2020 as against Rs 548.10 crore for the same quarter in the previous year. Total income of the company increased 30.50% at Rs 3889.10 crore for Q1FY21 as compared Rs 2980.10 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported 12.11% fall in its net profit of associate at Rs 594.60 crore for the quarter ended June 30, 2020 as against Rs 676.50 crore for the same quarter in the previous year. However, total income of the company increased by 5.25% at Rs 4513.60 crore for Q1FY21 as compared Rs 4288.30 crore for the corresponding quarter previous year.